Funding the cure with genetherapy
Rooted in hope.
Gene therapy goes beyond treatment—it rewrites the genetic error at its source, offering hope for a durable, potentially lifelong cure.
CURRENT RARE GENETIC DISORDER
2026 Research Fund for Sialidosis
raised of $900,000 goal
Powering NEU1 gene & enzyme replacement studies through December 2026
500 Individual donors
Dec 31, 2026 Campaign close
100% Goes directly to mission programs
Want to know about Sialidosis?
Our first mission is Sialidosis—an ultra-rare genetic disorder. By funding groundbreaking gene therapy research, we’re bringing hope to families and driving the search for transformative treatments.
Sialidosis is a progressive lysosomal storage disorder that gradually steals mobility, vision, and neurological function, profoundly affecting patients and their families.
How can you Help??
Our Champion Partners
Businesses and organizations helping fund the fight against Sialidosis.
Stage Adda
Stage Adda is an all-in-one platform to sell, manage, and experience live events.
Stage Adda has championed our cause by quickly accepting it and featuring it on their website, adding a donation option to their ticketing system, and philanthropically donating 10% of proceeds to the cause.